Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype
Clinical trial NCT04741438 · UNKNOWN
Trial details
- NCT number
- NCT04741438
- Sponsor
- Centre Leon Berard
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-30
- Primary completion
- 2025-02-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.